PTD-DBM: the complete guide.

The short version.

If you read nothing else, read this. The whole guide in a handful of bullets.

Quick reference.

What is PTD-DBM?

PTD-DBM is a short peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. The name describes its two halves: a Dishevelled-binding motif (DBM), the working part, fused to a protein transduction domain (PTD), a carrier that helps it cross into cells.

It came out of the lab of Dr. Kang-Yell Choi at Yonsei University in South Korea, which has spent years studying a protein called CXXC5 and its role in the Wnt signaling pathway. Wnt is one of the core signals that tells hair follicles to enter their growth phase, and CXXC5 acts as a brake on it.

The version sold by vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a hormone, and not a stimulant. People reach for it for one reason: it is studied for waking dormant follicles in pattern hair loss by releasing that Wnt brake right in the scalp.

Worth saying plainly: PTD-DBM is not an approved medicine anywhere. It is sold strictly for research use only, and every efficacy result so far comes from mouse studies. There is no published human randomized trial for hair loss. We get into what that means further down.

How it works in the body.

You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.

The core idea is a brake and an accelerator. Wnt signaling is the accelerator for hair growth; CXXC5 is the brake. PTD-DBM is built to disable the brake, locally, in the skin where you apply it.

• Blocking CXXC5. CXXC5 normally grabs onto a scaffolding protein called Dishevelled and shuts down Wnt signaling. PTD-DBM slips into that same docking spot and sits there, so CXXC5 can no longer attach and apply the brake.
• Freeing the Wnt pathway. With CXXC5 out of the way, Wnt/β-catenin signaling can run, and that is the signal hair follicles need to re-enter their growth (anagen) phase. In mouse models this produced visible regrowth.
• The DHT link. Choi lab work found that DHT, the hormone behind pattern baldness, raises CXXC5 in balding scalp. That gives a tidy rationale for targeting CXXC5 specifically in androgenetic hair loss.

How to take it: routes of administration.

PTD-DBM is a topical peptide. There is no meaningful injectable or oral version, so the real questions are concentration and whether you pair it with microneedling. Here is the honest comparison.

So which should a beginner pick? Topical plus light microneedling is the answer almost everyone lands on, because the peptide does little if it cannot get past the surface of the skin. Plain topical is simpler but likely weaker. There is no reason to chase an injectable or oral form.

Dosing by goal.

There is no single official dose for PTD-DBM, because it is not an approved medicine. What follows is the protocol pattern people commonly run, drawn from the research and community use. The defining feature is that it is slow and measured in months.

First two months

The common starting pattern is a 0.5–1 mg/mL solution applied to the scalp about once a week, typically right after a microneedling session. This is the more frequent loading stretch of the protocol.

Months three to six

People then space applications out to roughly once every 10 to 15 days at the same concentration. The idea is to maintain the effect without applying as often, while still microneedling on a light schedule.

Paired with valproic acid

The original research combined PTD-DBM with topical valproic acid, which pushes the same Wnt pathway from a different angle. Many people layer the two, applying both to the scalp on the same routine.

Cycling and timing.

A cycle just means a defined run of time on the peptide, followed by a break. For PTD-DBM the common pattern is a roughly six month course, weekly at first then every 10 to 15 days, rather than applying it forever.

Why not just run it indefinitely? Mostly because the long-term human safety data does not exist yet. The cautious and widely followed approach is to run a focused multi-month block, assess, then take a break.

• Hold the schedule through your first couple of months, applying weekly at roughly even spacing.
• Step down, do not just quit cold if you want to maintain, moving to every 10 to 15 days after the loading stretch.
• Take a real break after a course before considering another. If shedding picks up or nothing changes, that is a conversation for a licensed provider.

Stacking PTD-DBM.

PTD-DBM is rarely run alone for hair. It is almost always paired with a method or a second compound aimed at the same Wnt-driven goal.

See full recipes, dosing, and how people run them on the stacks page.

Side effects and safety.

In the reports we see, topical PTD-DBM is generally described as well tolerated, with side effects that tend to be mild, local, and tied to the application or the microneedling. The ones people mention most often are:

• Scalp irritation or redness, especially right after microneedling, which opens the skin.
• Mild itching or dryness at the application area.
• Temporary tenderness from the dermaroller rather than the peptide itself.
• Rare allergic-type reactions, a reason to patch test before going all-in.

Who should be cautious.

Some people have clear reasons to be extra careful, or to avoid PTD-DBM entirely until they have spoken with a licensed provider.

• Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
• A history of cancer, or active cancer. Because PTD-DBM activates Wnt/β-catenin signaling, a pathway some cancers depend on, caution is widely advised. This is a conversation for an oncologist, not a forum.
• Sensitive or broken scalp skin. Microneedling on inflamed, sunburned, or infected skin is a bad idea; let the scalp heal first.
• Anyone on other medications. If you take prescription drugs or manage a chronic condition, talk to your provider first.

And the universal one: whoever you are, talk to a licensed healthcare provider before starting PTD-DBM. This guide is educational, not a substitute for personalized medical advice.

Where to buy it safely.

This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.

• Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
• Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
• Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
• Be skeptical of suspiciously cheap listings with no testing behind them.

That is exactly the comparison we put together. On our PTD-DBM product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.

Questions, answered straight.